雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Pneumocystis pneumonia(PCP) Kazuaki FUKUSHIMA 1,2 , Naoki YANAGISAWA 3,4,5 1Department of Infectious Diseases Tokyo Metropolitan Komagome Hospital 2Master of Tropical Medicine School of Tropical Medicine and Global Health Nagasaki University 3Bureau of International Health Cooperation National Center for Global Health and Medicine 4Department of Environmental Health Harvard T.H. Chan School of Public Health 5Department of General Medicine Kyorin University School of Medicine pp.185-197
Published Date 2019/1/1
DOI https://doi.org/10.11477/mf.3102200611

閲覧方法のご案内

この論文を閲覧するためにはログインが必要になります。
パスワードを忘れた場合 新しくユーザー登録する 施設共通IDをご利用の方はこちらから

PPV購入案内

1,320円 (1,200円+税10%) こちらは、185ページから197ページの文献です。
PPV(ペイ・パー・ビュー)とは、論文(記事)単位で購入・閲覧ができるサービスです。
購入には医書.jp本会員登録が必要です。



会員登録完了後に改めて上記「購入サイトへ」を選択してください。
または「購入サイトへ」選択後に「購入ログイン」、「新規会員登録」の順に進んでください。

会員登録について詳しくはをご確認ください。
  • Abstract
  • Look Inside
  • Reference

Pneumocystis pneumonia (PCP) is an opportunistic infection caused by Pneumocystis jirovecii. Those at an increased risk of acquiring PCP include patients infected with HIV and a low CD4 count (usually <200cells/μL), hematopoietic stem cell and solid organ transplant recipients, those with cancer (especially hematologic malignancies) and rheumatologic disease, and those receiving glucocorticoids, chemotherapeutic agents, and other immunosuppressive medications. The clinical manifestations of PCP are diverse and greatly affected by the underlying condition. The clinical course of non-HIV-related PCP (NH-PCP) is rapid and typically presents as fulminant respiratory failure, whereas HIV-related PCP (HIV-PCP) is usually indolent. The definitive diagnosis of PCP requires detection of the organism from respiratory specimens usually obtained by bronchoscopy. However, clinicians are often challenged to make a definitive diagnosis due to the inability to obtain the necessary specimen. Therefore, a presumptive diagnosis is often made by serum tests, imaging findings and molecular techniques. Appropriate risk evaluation and antimicrobial prophylaxis is essential for PCP prevention. Clinicians should be aware of the many side effects caused by anti-PCP drugs. Adjunctive corticosteroid administration is recommended for moderate to severe HIV-PCP, but its efficacy in patients with NH-PCP remains to be elucidated.


Copyright © 2019, MEDICAL SCIENCES INTERNATIONAL, LTD. All rights reserved.

基本情報

電子版ISSN 2186-7852 印刷版ISSN 1883-4833 メディカル・サイエンス・インターナショナル

関連文献

もっと見る

文献を共有